Free Trial

Ventyx Biosciences (VTYX) Short Interest Ratio & Short Volume

$4.37
-0.08 (-1.80%)
(As of 05/24/2024 ET)

Ventyx Biosciences Short Interest Data

Current Short Interest
8,410,000 shares
Previous Short Interest
8,380,000 shares
Change Vs. Previous Month
+0.36%
Dollar Volume Sold Short
$31.45 million
Short Interest Ratio
2.2 Days to Cover
Last Record Date
April 30, 2024
Outstanding Shares
70,499,000 shares
Float Size
56,850,000 shares
Short Percent of Float
14.79%
Today's Trading Volume
341,647 shares
Average Trading Volume
913,055 shares
Today's Volume Vs. Average
37%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Ventyx Biosciences ?

Sign up to receive the latest short interest report for Ventyx Biosciences and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

VTYX Short Interest Over Time

VTYX Days to Cover Over Time

VTYX Percentage of Float Shorted Over Time

Ventyx Biosciences Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/30/20248,410,000 shares $31.45 million +0.4%14.8%2.2 $3.74
4/15/20248,380,000 shares $39.13 million -9.1%17.5%2.2 $4.67
3/31/20249,220,000 shares $50.71 million -2.4%19.6%2.2 $5.50
3/15/20249,450,000 shares $72.77 million +2.8%20.1%2.2 $7.70
2/29/20249,190,000 shares $65.07 million +64.4%19.5%2.1 $7.08
2/15/20245,590,000 shares $13.98 million +15.0%11.9%1.4 $2.50
1/31/20244,860,000 shares $10.25 million -2.4%10.9%1.6 $2.11
1/15/20244,980,000 shares $11.11 million -6.9%11.2%1.6 $2.23
12/31/20235,350,000 shares $13.21 million -26.2%N/A0 $2.47
12/15/20237,250,000 shares $16.31 million -1.5%16.3%2.7 $2.25
11/30/20237,360,000 shares $15.90 million +24.5%16.5%3.2 $2.16
11/15/20235,910,000 shares $13.95 million -20.4%13.3%3 $2.36
10/31/20237,420,000 shares $107.00 million -13.9%17.0%4.9 $14.42
10/15/20238,620,000 shares $159.04 million -7.7%19.7%12.1 $18.45
9/30/20239,340,000 shares $324.38 million -1.5%21.4%15.4 $34.73
9/15/20239,480,000 shares $345.07 million +3.3%21.7%15.9 $36.40
8/31/20239,180,000 shares $307.53 million -1.5%20.7%13.9 $33.50
8/15/20239,320,000 shares $285.66 million -0.1%21.0%13.1 $30.65
7/31/20239,330,000 shares $345.68 million -1.0%22.3%13 $37.05
7/15/20239,420,000 shares $337.61 million -4.0%22.5%12.8 $35.84
6/30/20239,810,000 shares $321.77 million +9.6%24.1%11.9 $32.80
6/15/20238,950,000 shares $299.02 million +8.0%22.1%10.6 $33.41
5/31/20238,290,000 shares $285.76 million +7.1%20.5%10 $34.47
5/15/20237,740,000 shares $278.64 million +6.2%19.2%9.1 $36.00
4/30/20237,290,000 shares $274.10 million +7.1%19.2%8.6 $37.60
4/15/20236,810,000 shares $203.28 million -14.8%18.0%7.4 $29.85
3/31/20237,990,000 shares $267.67 million +37.3%22.5%9.5 $33.50
3/15/20235,820,000 shares $217.67 million +14.6%15.9%7.8 $37.40
2/28/20235,080,000 shares $219.71 million +10.2%14.7%6.7 $43.25
2/15/20234,610,000 shares $206.71 million +27.7%13.3%6.4 $44.84
1/31/20233,610,000 shares $151.62 million -12.6%10.2%5.2 $42.00
1/15/20234,130,000 shares $143.60 million +9.3%11.9%6.9 $34.77
12/30/20223,780,000 shares $123.95 million +0.5%11.0%6.6 $32.79
12/15/20223,760,000 shares $125.77 million +9.6%11.3%6.7 $33.45
11/30/20223,430,000 shares $99.44 million +6.5%11.7%4.7 $28.99
11/15/20223,220,000 shares $83.01 million -13.4%11.3%4.8 $25.78
10/31/20223,720,000 shares $120.42 million -6.8%15.1%5.4 $32.37
10/15/20223,990,000 shares $115.43 million +8.1%18.0%6.2 $28.93
9/30/20223,690,000 shares $128.82 million +5.4%16.7%6.1 $34.91
9/15/20223,500,000 shares $131.32 million -20.1%15.8%6 $37.52
2024's Must-Watch Stocks! (Ad)

Welcome to a year of unparalleled opportunities! Dive into our exclusive guide, "9 Stocks Set to Soar," meticulously selected to elevate your portfolio in 2024. Step into 2024 with confidence and the right assets at your fingertips. Click below to opt-in and receive up to two additional free bonus subscriptions. Unsubscribe at any time.

[Unlock Your Report Now]
8/31/20224,380,000 shares $89.35 million +0.9%19.8%8.7 $20.40
8/15/20224,340,000 shares $80.72 million -1.1%19.4%17.5 $18.60
7/31/20224,390,000 shares $66.33 million +7.1%19.8%22.8 $15.11
7/15/20224,100,000 shares $61.50 million +7.9%18.4%21.8 $15.00
6/30/20223,800,000 shares $46.47 million +18.8%17.1%19.2 $12.23
6/15/20223,200,000 shares $41.82 million +3.6%14.4%16.3 $13.07
5/31/20223,090,000 shares $54.11 million +9.6%13.9%18.4 $17.51
5/15/20222,820,000 shares $42.05 million +8.5%12.7%18.7 $14.91
4/30/20222,600,000 shares $37.78 million -9.7%11.7%18.7 $14.53
4/15/20222,880,000 shares $37.99 million +5.1%13.0%20.4 $13.19
3/31/20222,740,000 shares $37.18 million +11.8%12.5%20.9 $13.57
3/15/20222,450,000 shares $25.73 million +7.9%11.9%20.2 $10.50
2/28/20222,270,000 shares $26.54 million +9.1%11.0%14.5 $11.69
2/15/20222,080,000 shares $25.79 million +5.6%10.1%12.2 $12.40
1/31/20221,970,000 shares $32.03 million +22.4%8.1%10.8 $16.26
1/15/20221,610,000 shares $25.33 million +10.3%6.6%7.9 $15.73
12/31/20211,460,000 shares $29.00 million No ChangeN/A0 $19.86

VTYX Short Interest - Frequently Asked Questions

What is Ventyx Biosciences' current short interest?

Short interest is the volume of Ventyx Biosciences shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 8,410,000 shares of VTYX short. 14.79% of Ventyx Biosciences' shares are currently sold short. Learn More on Ventyx Biosciences' current short interest.

What is a good short interest ratio for Ventyx Biosciences?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. VTYX shares currently have a short interest ratio of 2.0. Learn More on Ventyx Biosciences's short interest ratio.

What is a good short interest percentage for Ventyx Biosciences?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 14.79% of Ventyx Biosciences' floating shares are currently sold short.

Is Ventyx Biosciences' short interest increasing or decreasing?

Ventyx Biosciences saw a increase in short interest in April. As of April 30th, there was short interest totaling 8,410,000 shares, an increase of 0.4% from the previous total of 8,380,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Ventyx Biosciences' float size?

Ventyx Biosciences currently has issued a total of 70,499,000 shares. Some of Ventyx Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Ventyx Biosciences currently has a public float of 56,850,000 shares.

How does Ventyx Biosciences' short interest compare to its competitors?

14.79% of Ventyx Biosciences' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Ventyx Biosciences: Nanobiotix S.A. (0.12%), Skye Bioscience, Inc. (0.13%), AC Immune SA (0.88%), Nkarta, Inc. (14.02%), Nektar Therapeutics (1.99%), Mersana Therapeutics, Inc. (8.92%), Precigen, Inc. (11.81%), Revance Therapeutics, Inc. (11.77%), UroGen Pharma Ltd. (18.89%), ADC Therapeutics SA (1.43%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks.

What does it mean to sell short Ventyx Biosciences stock?

Short selling VTYX is an investing strategy that aims to generate trading profit from Ventyx Biosciences as its price is falling. VTYX shares are trading down $0.08 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Ventyx Biosciences?

A short squeeze for Ventyx Biosciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of VTYX, which in turn drives the price of the stock up even further.

How often is Ventyx Biosciences' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VTYX, twice per month. The most recent reporting period available is April, 30 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:VTYX) was last updated on 5/26/2024 by MarketBeat.com Staff

From Our Partners